Bank of Montreal
PMN icon

Bank of Montreal’s ProMIS Neurosciences PMN Stock Holding History

Bank of Montreal’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Buy
+11,371
New +$123K ﹤0.01% 3120
2025
Q4 		– Sell
-1,215
Closed -$13.1K – 3786
2025
Q3 		$13.1K Hold
1,215
– – ﹤0.01% 3335
2025
Q2 		$14.9K Hold
1,215
– – ﹤0.01% 3325
2025
Q1 		$21.5K Hold
1,215
– – ﹤0.01% 3208
2024
Q4 		$28.7K Hold
1,215
– – ﹤0.01% 3205
2024
Q3 		$40.1K Hold
1,215
– – ﹤0.01% 3459
2024
Q2 		$55.3K Hold
1,215
– – ﹤0.01% 3406
2024
Q1 		$59.8K Buy
+1,215
New +$60.1K ﹤0.01% 3409

Other funds holding PMN

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Bank of Montreal's PMN Position: Q2 2026 in Review

Bank of Montreal opened a new position in ProMIS Neurosciences (PMN) in Q2 2026: 11,371 shares worth $150K. The stake represents ﹤0.01% of the portfolio and ranks #3120 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in PMN as recently as Q3 2025.

Bank of Montreal first reported a position in PMN in Q1 2024 and has held it in 8 quarters since. 6 funds tracked by Wall St. Rank hold PMN as of Q2 2026.

  • Bank of Montreal held 11,371 shares of ProMIS Neurosciences worth $150K as of Q2 2026.
  • ProMIS Neurosciences was a new Bank of Montreal position in Q2 2026.
  • ProMIS Neurosciences made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3120 holding.
  • Bank of Montreal first reported a position in ProMIS Neurosciences in Q1 2024 and has held it in 8 quarters since.
  • 6 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.